Sourced fact
The News
Convicted prisoner Krista Buckeye has narrowly escaped execution in Tennessee after two failed attempts to carry out lethal injection. Here are the details of the incident and its aftermath:
Following the unsuccessful attempt to execute her on September 30, Buckeye was transferred to the hospital where she is currently able to walk and speak limitedly. According to attorney Joel Zivot, the likely cause was that most of the drug did not enter her bloodstream, but instead accumulated under her skin. Zivot told the BBC, "Most of the pentobarbital accumulated in her arms, which is why she remained alive."
Tennessee Governor Bill Lee has ordered an independent investigation into the incident and has halted all executions in the state until the end of the year. The mother of the victim, Colleen Slemmer, stated that the process was a horrifying failure. The Tennessee Department of Correction stated that the protocol does not allow for any additional procedures after the first and second injections fail.
It is important to note that Buckeye suffers from a rare medical condition called thrombocytopenia, which increases the risk of blood clotting. Her attorney warned that this condition could prevent the drug from entering her bloodstream. Seven needles were used to establish IV lines, resulting in Buckeye's screaming and struggling to breathe during the attempt.
Buckeye's health condition and its impact on her legal future are now being evaluated. Her attorney has requested that her sentence be changed from death to life in prison without parole. According to attorney John Mills, the U.S. Supreme Court has not prevented second executions in the past. The U.S. Supreme Court allowed Alabama to proceed with a second execution of Keith Tharpe Smith after the first attempt failed in 2024.
Analysis & context
Analysis & Context
From an analytical perspective, this incident sheds light on the legal and ethical challenges associated with carrying out the death penalty. The failure of the execution raises questions about the efficacy and safety of the protocols used. It also raises questions about the ability of authorities to ensure that the execution is carried out without unnecessary suffering.
In the broader context, this incident reflects the challenges faced by American states in obtaining the necessary materials for executions. Many pharmaceutical companies have refused to supply the materials needed for lethal injections, making current protocols unreliable at times.
This incident also highlights the legal and judicial challenges associated with carrying out the death penalty. While the U.S. Supreme Court has not prevented second attempts in the past, the failure of the first execution may raise questions about the justice and legitimacy of imposing the ultimate punishment.
